RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MedCap AB (publ) Stock

MedCap AB (publ) Equity 2024

MedCap AB (publ) Equity

1.02 B SEK

Ticker

MCAP.ST

ISIN

SE0009160872

WKN

A2ASQ7

In 2024, MedCap AB (publ)'s equity was 1.02 B SEK, a 19.46% increase from the 856.3 M SEK equity in the previous year.

MedCap AB (publ) Aktienanalyse

What does MedCap AB (publ) do?

MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing MedCap AB (publ)'s Equity

MedCap AB (publ)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding MedCap AB (publ)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating MedCap AB (publ)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

MedCap AB (publ)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in MedCap AB (publ)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about MedCap AB (publ) stock

What is the equity of MedCap AB (publ) this year?

MedCap AB (publ) has equity of 1.02 B SEK this year.

What was the equity of MedCap AB (publ) compared to the previous year?

The equity of MedCap AB (publ) has increased/decreased by 19.46% increased compared to the previous year.

What impact does a high equity have on investors of MedCap AB (publ)?

A high equity is advantageous for investors of MedCap AB (publ) as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of MedCap AB (publ)?

A low equity can be a risk for investors of MedCap AB (publ), as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of MedCap AB (publ) affect the company?

An increase in equity of MedCap AB (publ) can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of MedCap AB (publ) affect the company?

A reduction in equity of MedCap AB (publ) can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of MedCap AB (publ)?

Some factors that can affect the equity of MedCap AB (publ) include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of MedCap AB (publ) so important for investors?

The equity of MedCap AB (publ) is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can MedCap AB (publ) take to change the equity?

To change equity, MedCap AB (publ) can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does MedCap AB (publ) pay?

Over the past 12 months, MedCap AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedCap AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of MedCap AB (publ)?

The current dividend yield of MedCap AB (publ) is .

When does MedCap AB (publ) pay dividends?

MedCap AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MedCap AB (publ)?

MedCap AB (publ) paid dividends every year for the past 0 years.

What is the dividend of MedCap AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is MedCap AB (publ) located?

MedCap AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von MedCap AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MedCap AB (publ) from 11/5/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did MedCap AB (publ) pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of MedCap AB (publ) in the year 2023?

In the year 2023, MedCap AB (publ) distributed 0 SEK as dividends.

In which currency does MedCap AB (publ) pay out the dividend?

The dividends of MedCap AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MedCap AB (publ)

Our stock analysis for MedCap AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedCap AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.